Wilson Sonsini Goodrich & Rosati advised General Atlantic on patent matters related to the transaction.Seaport Therapeutics (Seaport), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
